CA2274675A1 - Complexe vegf-b/recepteur et utilisations dudit complexe - Google Patents
Complexe vegf-b/recepteur et utilisations dudit complexe Download PDFInfo
- Publication number
- CA2274675A1 CA2274675A1 CA002274675A CA2274675A CA2274675A1 CA 2274675 A1 CA2274675 A1 CA 2274675A1 CA 002274675 A CA002274675 A CA 002274675A CA 2274675 A CA2274675 A CA 2274675A CA 2274675 A1 CA2274675 A1 CA 2274675A1
- Authority
- CA
- Canada
- Prior art keywords
- vegf
- receptor
- binding
- flt
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne d'une part des complexes de facteurs B de croissance de l'endothélium vasculaire (VEGF-B) et le récepteur de la tyrosine kinase Flt-1; d'autre part, l'utilisation desdits complexes VEGF-B/Flt-1 dans des dosages en vue d'identifier le VEGF-B et les analogues de VEGF-B caractérisés par le fait qu'ils ont sensiblement la même affinité de liaison vis-à-vis d'un récepteur de surface cellulaire tel que le VEGF-B, et/ou qu'ils favorisent une réponse cellulaire induite par VEGF-B ou s'opposent à celle-ci; enfin, l'invention concerne les partenaires de liaison spécifiques desdits complexes de VEGF-B/Flt-1, par exemple, des anticorps.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3369796P | 1996-12-20 | 1996-12-20 | |
US60/033,697 | 1996-12-20 | ||
PCT/US1997/023533 WO1998028621A1 (fr) | 1996-12-20 | 1997-12-19 | Complexe vegf-b/recepteur et utilisations dudit complexe |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2274675A1 true CA2274675A1 (fr) | 1998-07-02 |
Family
ID=21871932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002274675A Abandoned CA2274675A1 (fr) | 1996-12-20 | 1997-12-19 | Complexe vegf-b/recepteur et utilisations dudit complexe |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0960334A1 (fr) |
JP (1) | JP2000516478A (fr) |
AU (1) | AU742779B2 (fr) |
CA (1) | CA2274675A1 (fr) |
WO (1) | WO1998028621A1 (fr) |
ZA (1) | ZA9711456B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783953B1 (en) | 1998-12-22 | 2004-08-31 | Janssen Pharmaceutica N.V. | Vascular endothelial growth factor-X |
WO2005087808A2 (fr) | 2004-03-05 | 2005-09-22 | Ludwig Institute For Cancer Research | Matieres et procedes de constructions de liaison de facteurs de croissance |
US20070111326A1 (en) * | 2005-11-14 | 2007-05-17 | Abbott Laboratories | Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia |
PL2548578T3 (pl) | 2006-05-17 | 2014-12-31 | The Ludwig Institute For Cancer Res | Kierowanie regulacją transporterów kwasów tłuszczowych przez VEGF-B, w celu modulowania ludzkich chorób |
DK2547359T3 (en) | 2010-03-15 | 2016-06-06 | The Board Of Trustees Of The Univ Of Illionis | Inhibitors of beta integrin G-protein alpha subunit-BINDING INTERACTIONS |
WO2012087943A2 (fr) | 2010-12-20 | 2012-06-28 | The Regents Of The University Of Michigan | Inhibiteurs de l'interaction de liaison entre le récepteur du facteur de croissance épidermique et la protéine de choc thermique 90 |
RU2699007C2 (ru) | 2013-02-18 | 2019-09-02 | Ведженикс Пти Лимитед | Молекулы, связывающие лиганды, и их применение |
JP2016036322A (ja) * | 2014-08-11 | 2016-03-22 | 日本化薬株式会社 | 血管新生因子と結合するキメラタンパク質 |
US20220347113A1 (en) | 2019-11-07 | 2022-11-03 | The Board Of Trustees Of The University Of Illinois | Peptides and methods of treating sepsis, atherosclerosis, thrombosis, stroke, heart attack and inflammation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5712395A (en) * | 1992-11-13 | 1998-01-27 | Yissum Research Development Corp. | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
US5928939A (en) * | 1995-03-01 | 1999-07-27 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-b and dna coding therefor |
-
1997
- 1997-12-19 CA CA002274675A patent/CA2274675A1/fr not_active Abandoned
- 1997-12-19 WO PCT/US1997/023533 patent/WO1998028621A1/fr not_active Application Discontinuation
- 1997-12-19 AU AU56136/98A patent/AU742779B2/en not_active Ceased
- 1997-12-19 ZA ZA9711456A patent/ZA9711456B/xx unknown
- 1997-12-19 JP JP10528986A patent/JP2000516478A/ja active Pending
- 1997-12-19 EP EP97952553A patent/EP0960334A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU742779B2 (en) | 2002-01-10 |
EP0960334A1 (fr) | 1999-12-01 |
WO1998028621A1 (fr) | 1998-07-02 |
AU5613698A (en) | 1998-07-17 |
JP2000516478A (ja) | 2000-12-12 |
ZA9711456B (en) | 1998-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Roeckl et al. | Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2 | |
EP0956339B1 (fr) | Facteur d recombinant de croissance des cellules endotheliales vasculaires (vegf-d) | |
US6221839B1 (en) | FIt4 ligand and methods of use | |
EP0694042B1 (fr) | Inhibiteur du facteur de croissance de cellules endotheliales vasculaires | |
CA2224093C (fr) | Facteur de croissance endotheliale vasculaire 2 humain | |
US6355440B1 (en) | Assays using receptors for fibroblast growth factors | |
US20050176103A1 (en) | Vascular endothelial growth factor 2 | |
US20060025331A1 (en) | Vascular endothelial growth factor 2 | |
AU780593B2 (en) | Novel neuropilin/growth factor binding and uses thereof | |
AU742779B2 (en) | VEGF-B/receptor complex and uses thereof | |
Kumar et al. | Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates | |
CA2413012A1 (fr) | Facteur de croissance endotheliale vasculaire 2 humain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |